Moat Ross sold KNSA
September 1, 2026 · Form 4 insider transaction
Moat Ross sold 4,007 shares of Kiniksa Pharmaceuticals International, plc at $79.28 per share, a transaction worth $317.7K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,007
Price
$79.28
Total value
$317.7K
InsiderMoat Ross
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeF: Shares withheld for taxes
Transaction dateSeptember 1, 2026
Filing dateSeptember 3, 2026
Shares owned after16,307
OwnershipDirect
10b5-1 planNo
AmendedNo